Ing Soo Tiong

3.7k total citations · 1 hit paper
55 papers, 1.3k citations indexed

About

Ing Soo Tiong is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ing Soo Tiong has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 19 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Ing Soo Tiong's work include Acute Myeloid Leukemia Research (37 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Histone Deacetylase Inhibitors Research (11 papers). Ing Soo Tiong is often cited by papers focused on Acute Myeloid Leukemia Research (37 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Histone Deacetylase Inhibitors Research (11 papers). Ing Soo Tiong collaborates with scholars based in Australia, New Zealand and United Kingdom. Ing Soo Tiong's co-authors include Andrew H. Wei, Suresh Agarwal, Walter Fiedler, Anoop Enjeti, Kaffa Fakouhi, Michael R. Savona, Brenda Chyla, Jing-Zhou Hou, Roland B. Walter and Sang‐Min Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ing Soo Tiong

49 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

2019 456 citations Andrew H. Wei, Stephen A. Strickland et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Ing Soo Tiong

Since Specialization

Citations

This map shows the geographic impact of Ing Soo Tiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ing Soo Tiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ing Soo Tiong more than expected).

Fields of papers citing papers by Ing Soo Tiong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ing Soo Tiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ing Soo Tiong. The network helps show where Ing Soo Tiong may publish in the future.

Co-authorship network of co-authors of Ing Soo Tiong

This figure shows the co-authorship network connecting the top 25 collaborators of Ing Soo Tiong. A scholar is included among the top collaborators of Ing Soo Tiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ing Soo Tiong. Ing Soo Tiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic variation in DDX41 identified through clinical sequencing 2025 ·British Journal of Haematology ·(unknown), Ing Soo Tiong, Sally M. Hunter, Nicole den Elzen, (unknown), (unknown), (unknown), Ella R. Thompson, Michelle Tan, (unknown), Lucy C. Fox, Piers Blombery	0
2	Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT) 2025 ·Blood Advances ·Chong Chyn Chua, Sun Loo, Chun Yew Fong, Stephen B. Ting, Ing Soo Tiong, (unknown), Natasha S. Anstee, Adam Ivey, Michael Ashby, (unknown), John Reynolds, Andrew W. Roberts, Andrew H. Wei	4
3	Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC) 2024 ·Journal of Clinical Oncology ·Ing Soo Tiong, Devendra Hiwase, (unknown), Ashish Bajel, (unknown), (unknown), John Reynolds, Natasha S. Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, (unknown), Shaun Fleming, Chun Yew Fong, (unknown), Piers Blombery, Richard Dillon, Adam Ivey, Andrew H. Wei	18
4	Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia 2024 ·Blood ·Sun Loo, Nicola Potter, Adam Ivey, Jenny O’Nions, R C Moon, Jelena Jovanović, Chun Yew Fong, Natasha S. Anstee, Ing Soo Tiong, Jad Othman, Chong Chyn Chua, (unknown), (unknown), Shaun Fleming, Nigel H. Russell, David Ritchie, Ashish Bajel, Hsin‐An Hou, Richard Dillon, Andrew H. Wei	4
5	Observations from a national sample exchange program for molecular haematology testing 2024 ·Pathology ·Clare Gould, Michelle McBean, Ella R. Thompson, (unknown), Ing Soo Tiong, (unknown), (unknown)	1
6	Efficacy and safety results from the COMMANDS trial: A phase 3 study evaluating luspatercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naive transfusion-dependent (TD) patients (pts) with lower-risk myelodysplastic syndromes (LR-MDS). 2023 ·Journal of Clinical Oncology ·Guillermo Garcia‐Manero, Uwe Platzbecker, Valeria Santini, Amer M. Zeidan, Pierre Fenaux, Rami S. Komrokji, Jake Shortt, David Valcárcel, Anna Jonášová, Sophie Dimicoli‐Salazar, Ing Soo Tiong, Chien‐Chin Lin, Jiahui Li, (unknown), (unknown), Jeevan K. Shetty, (unknown), Carlo Finelli, Thomas Cluzeau, Matteo Giovanni Della Porta	0
7	Evaluation of T‐cell clonality by anti‐TRBC1 antibody‐based flow cytometry and correlation with T‐cell receptor sequencing 2023 ·British Journal of Haematology ·Phillip Nguyen, Tamia Nguyen, (unknown), Ing Soo Tiong, (unknown), Vuong Nguyen, Neil Came, Piers Blombery, David Westerman	2
8	Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia 2023 ·SHILAP Revista de lepidopterología ·(unknown), Phillip Nguyen, David J. Byrne, (unknown), Georgina L. Ryland, Tamia Nguyen, Mary Ann Anderson, Seong Lin Khaw, (unknown), Ing Soo Tiong, Elaine Sanij, Piers Blombery	3
9	Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication 2023 ·International Journal of Molecular Sciences ·Ing Soo Tiong, Sun Loo	17
10	Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide 2023 ·SHILAP Revista de lepidopterología ·Ing Soo Tiong, William Stevenson, Meaghan Wall, (unknown), John F. Seymour, Melita Kenealy, Piers Blombery, (unknown)	2
11	Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms 2022 ·American Journal of Hematology ·Mithun Vinod Shah, Rakchha Chhetri, (unknown), Chung Hoow Kok, Naseema Gangat, Hassan B. Alkhateeb, Aref Al‐Kali, Mrinal M. Patnaik, Anmol Baranwal, Patricia T. Greipp, Rong He, Kebede H. Begna, Ing Soo Tiong, Andrew H. Wei, Devendra Hiwase	8
12	Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome 2022 ·Blood ·Sun Loo, Richard Dillon, Adam Ivey, Natasha S. Anstee, Jad Othman, Ing Soo Tiong, Nicola Potter, Jelena Jovanović, Manohursingh Runglall, (unknown), Ashish Bajel, David Ritchie, (unknown), (unknown), Michelle McBean, Amanda Gilkes, Ian Thomas, Sean Johnson, Nigel H. Russell, Andrew H. Wei	42
13	Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement 2022 ·Pathology ·Anoop Enjeti, Rishu Agarwal, Piers Blombery, Lynette Chee, Chong Chyn Chua, Andrew Grigg, Nada Hamad, Harry Iland, Steven Lane, Andrew C. Perkins, Deepak Singhal, (unknown), Ing Soo Tiong, David M. Ross	3
14	The Natural History of NPM1MUT Measurable Residual Disease (MRD) Positivity after Completion of Chemotherapy in Acute Myeloid Leukemia (AML) 2020 ·Blood ·Ing Soo Tiong, Richard Dillon, Adam Ivey, Chung Hoow Kok, (unknown), (unknown), Ashish Bajel, Nicola Potter, Matthew Smith, Claire Hemmaway, Abin Thomas, Amanda Gilkes, Nigel H. Russell, Andrew H. Wei	3
15	Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy 2020 ·Journal of Clinical Oncology ·Chong Chyn Chua, Andrew W. Roberts, John Reynolds, Chun Yew Fong, Stephen B. Ting, Jessica M. Salmon, Sarah MacRaild, Adam Ivey, Ing Soo Tiong, Shaun Fleming, Fiona C. Brown, Sun Loo, Ian J. Majewski, Stefan K. Bohlander, Andrew H. Wei	117
16	Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study breakdown → 2019 ·Journal of Clinical Oncology ·Andrew H. Wei, Stephen A. Strickland, Jing-Zhou Hou, Walter Fiedler, Tara L. Lin, Roland B. Walter, Anoop Enjeti, Ing Soo Tiong, Michael R. Savona, Sang‐Min Lee, Brenda Chyla, Relja Popovic, Ahmed Hamed Salem, Suresh Agarwal, Tu Xu, Kaffa Fakouhi, Rod Humerickhouse, (unknown), John Hayslip, Gail J. Roboz	456
17	Comparison of Frontline Induction Therapy Using Idarubicin in Combination with High-Dose (HDAC3) Versus Intermediate-Dose Cytarabine (IDAC3) in Adult Acute Myeloid Leukemia 2017 ·Blood ·Ing Soo Tiong, Katherine Fielding, Chun Yew Fong, (unknown), Sharon Avery, Andrew Grigg, Andrew H. Wei	0
18	Baseline and treatment-related changes in thrombin generation in patients with multiple myeloma 2016 ·Leukemia & lymphoma ·Ing Soo Tiong, Susan Rodgers, (unknown), Simon McRae	18
19	Primary endometrial uterine Burkitt lymphoma in a 65-year-old woman 2015 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Ing Soo Tiong, Simone Petrich	1
20	Nonbacterial Thrombotic Endocarditis with ST-elevation Myocardial Infarction Treated with Percutaneous Coronary Aspiration Thrombectomy 2012 ·Heart Lung and Circulation ·Ing Soo Tiong, Michael Williams, David Pérez	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact